Insider Transactions in Q4 2022 at Bristol Myers Squibb CO (BMY)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 02
2022
|
Christopher S. Boerner Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,349
-3.02%
|
$109,269
$81.13 P/Share
|
|
Dec 02
2022
|
Christopher S. Boerner Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,637
+5.58%
|
-
|
|
Dec 02
2022
|
Rupert Vessey EVP & President, Research |
SELL
Payment of exercise price or tax liability
|
Direct |
4,498
-6.83%
|
$364,338
$81.13 P/Share
|
|
Dec 02
2022
|
Rupert Vessey EVP & President, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
8,792
+11.78%
|
-
|
|
Dec 02
2022
|
David V Elkins EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,498
-3.5%
|
$364,338
$81.13 P/Share
|
|
Dec 02
2022
|
David V Elkins EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,792
+6.4%
|
-
|
|
Nov 09
2022
|
Ann Powell EVP, Chief Human Resources |
SELL
Open market or private sale
|
Direct |
16,250
-32.19%
|
$1,300,000
$80.45 P/Share
|
|
Nov 07
2022
|
Rupert Vessey EVP & President, Research |
SELL
Open market or private sale
|
Direct |
45,910
-44.58%
|
$3,580,980
$78.88 P/Share
|
|
Nov 07
2022
|
Rupert Vessey EVP & President, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
52,604
+11.16%
|
$2,840,616
$54.85 P/Share
|